PMCF Study to Evaluate Safety of TIPMED TPM08 Total Knee Prosthesis Systems and TPM Revision Knee Prosthesis Systems
Multicenter, Prospective, Observational Post Market Clinical Follow-up Study to Evaluate Safety of TIPMED TPM08 Total Knee Prosthesis Systems and TPM Revision Knee Prosthesis Systems
1 other identifier
observational
190
1 country
5
Brief Summary
This is a observational multicenter study to assess the safety of TIPMED TPM08 Total Knee Prosthesis Systems and TPM Revision Knee Prosthesis Systems used for total knee arthroplasty or revision knee arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2022
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 22, 2022
CompletedFirst Submitted
Initial submission to the registry
May 27, 2022
CompletedFirst Posted
Study publicly available on registry
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 2, 2024
CompletedMay 25, 2025
May 1, 2025
1.9 years
May 27, 2022
May 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Safety data
Assessment of safety data during 12 months after surgery.
12 months
Eligibility Criteria
All eligible patients, who agree to participate in the study, treated with TIPMED TPM08 Primary Total or Revision Knee Prosthesis Systems will be included.
You may qualify if:
- Male and female subjects aged older than 18 years of age,
- The subjects with appropriate indication for primary total or revision knee arthroplasty,
- The subjects who used TIPMED TPM08 Primary Total or Revision Knee Prosthesis System in their surgery,
- Subjects not under legal disability,
- Subjects or guardian who is willing and able to sign the informed consent form.
You may not qualify if:
- \- Subjects in another interventional clinical trial will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Republic of Turkey Ministry of Health Balıkesir Provincial Health Directorate Ataturk City Hospital
Balıkesir, Altıeylül, 10100, Turkey (Türkiye)
Ege University Hospital
Izmir, Bornova, 35100, Turkey (Türkiye)
Republic of Turkey Ministry of Health Izmir Provincial Health Directorate Buca Seyfi Demirsoy Training And Research Hospital
Izmir, Buca, 35390, Turkey (Türkiye)
Republic of Turkey Ministry of Health Balıkesir Provincial Health Directorate Burhaniye Public Hospital
Balıkesir, Burhaniye, 10700, Turkey (Türkiye)
Republic of Turkey Ministry of Health Izmir Provincial Health Directorate Menemen Public Hospital
Izmir, Menemen, 35660, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Salih Kemal Aktuglu
Ege University Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 27, 2022
First Posted
June 1, 2022
Study Start
April 22, 2022
Primary Completion
April 2, 2024
Study Completion
April 2, 2024
Last Updated
May 25, 2025
Record last verified: 2025-05